Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-01 @ 6:51 AM
Study NCT ID:
NCT04579757
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2020-09-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Sponsor:
Hutchmed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2020-012-GLOB1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |